An expiration date: I send a certain thing more than one year until an expiration date.
Uh, it is characteristic 1 of the nasal drop product for the G nose allele cut M pharmaceutical products division OTC drug efficacy classification nasal inflammation. Antiallergic drug "cromoglicic acid sodium" holds the release of the allergy-induced material in check and relaxes a hard allergic symptom. 2. "Chlorpheniramine maleate" blocks receptor binding of the histamine causing an allergic symptom and controls sneezing and mucus. 3. I suppress fine weather and hyperemia of the nasal mucosa, and "naphazoline hydrochloride" improves a stuffy nose immediately. 4. "Glycyrrhizic acid dipotassium" relieves inflammation of the nose due to the allergic reaction. 5. I stay in the affected part, and liquid anyone is the nasal drop of the Moi strike type that it is hard to do. 6. I use an airless container (moving valve-style mist type) which can atomize it from all angles. Cannot do it precautions ■ (when do not protect it, a current symptom turns worse, and a side effect, an accident becomes easy to happen); 1. Please do not use the next person. Person 2 who has had an allergic symptom by the ingredient of this agent or this agent. After use, please do not do the control of a vehicle or the instrumentation. It is 3 (sleepiness may appear). Please do not make a long-term continuous use. ■Consultation すること 1. The next person, please talk with a doctor, a pharmacist or the registration distributor before use. (1) Person (3) pregnant women receiving allergic treatment such as person (2) hyposensitization treated by the doctor or person high blood pressure, heart disease, diabetes, thyroid gland functional disorder, symptom due to allergy to glaucoma (6) or symptom by other causes or unclear person 2 who received the diagnosis of the person (5) next which had woken up an allergy symptom by person (4) medicine considered to be pregnant. After use, as the side effect is possible when the next symptom appears, you cancel use promptly, and please talk with a doctor, a pharmacist or the registration distributor with this document. It is skin [a part concerned: a symptom]: A rash, a flare, an itch, a fine weather nose: Fine weather, a feeling of stimulation, nose bleed mind nervous system: The headache symptom that the next is rarely serious may be caused. In that case, please receive the medical treatment of the doctor promptly. [the name of the symptom: a symptom] a shock (anaphylaxis): After use, is immediate; of graze it sneezing of an itch of the skin, hives, the voice which itch, suffocation, heartbeat, clouded mental status appear. 3. When a symptom does not improve even if I use it for around three days, you cancel use, and please talk with a doctor, a pharmacist or the registration distributor with this document. 4. When you use it more than two weeks even if the improvement of the symptom is seen, please talk with a doctor, a pharmacist or the registration distributor with this document. As the other attention <attention in conjunction with an ingredient, the quantity> books agent includes alcohol, it may soak. The palliation of allergic symptom of the following nose by an effect, effect pollen, the house dust (indoor dust): Mucus (excessive nasal mucus), a stuffy nose, sneezing, a sluggishness (a head is heavy) use, a dose [age: once quantity: on 1st the use number of times] adult (15 years old or older): Please atomize it in both nasal cavities once. : I am younger than 15 years old 3-5 times (please put intervals more than three hours) of 7 years old or older: Please atomize it in both nasal cavities once. : Under 3-5 times (please put intervals more than three hours) of 7 years old: Please do not use it. Under ingredient quantity 100mL The second kind pharmaceutical products advertisement responsibility for the contents of an article such as ingredient quantity cromoglicic acid sodium 1 g chlorpheniramine maleate 0.25 g naphazoline hydrochloride 0.025 g glycyrrhizic acid dipotassium 0.3 g production sales company Daiichi Sankyo Co., Ltd. health care formulation air spray risk division: Energy 0242-85-7380 responsibility for the contents of an article: Energy registration distributor Kazuya Yamauchi